{"entities":{"Q9851":{"pageid":14012,"ns":120,"title":"Item:Q9851","lastrevid":205772,"modified":"2020-05-21T15:46:17Z","type":"item","id":"Q9851","labels":{"en":{"language":"en","value":"Richter S, et al. Invest N. Drugs (2014) cited as Ref 588 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9851$BB8092FD-0CCD-43CC-8FD8-D7C86455E6DB","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9851$C87983C0-E6EC-4079-9357-F8D7B3038F90","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Richter S","type":"string"},"datatype":"string"},"type":"statement","id":"Q9851$32EAE980-AA38-40C0-99C6-5F70869C2CCF","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1007/s10637-013-9965-4","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9851$57B9142D-7EF1-4076-B103-0E18A44EDC4F","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2014-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9851$69ED45DC-9411-481C-9066-1DAEF069AEB0","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Invest N. Drugs","type":"string"},"datatype":"string"},"type":"statement","id":"Q9851$9B349AE1-BC01-4E70-A70B-E66BA084E209","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"32","type":"string"},"datatype":"string"},"type":"statement","id":"Q9851$9C7F1854-3F55-40A0-BF32-034D75AF960D","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9851$3148ECC8-49AC-4A40-AC0D-88D8DE45A075","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"243-249","type":"string"},"datatype":"string"},"type":"statement","id":"Q9851$D001C0E4-03D2-421E-80C3-E0571BADA1C1","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Richter S, et al. Invest N. Drugs (2014) cited as Ref 588 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Richter_S,_et_al._Invest_N._Drugs_(2014)_cited_as_Ref_588_in_DOI:_10.1038/s41392-020-0110-5"}}}}}